Kisor May Be A New Dawn For Challenges To FDA Actions

By Beth Weinman, Douglas Hallward-Driemeier, Greg Levine, Emerson Siegle and Rebecca Williams (December 2, 2019, 2:38 PM EST) -- In Kisor v. Wilkie[1] — a closely watched case decided in a closely divided opinion toward the end of the U.S. Supreme Court's last term — the court upheld the doctrine of Auer deference, much to the surprise of many given the court's new conservative majority. Although technically a win for the government, the decision recast Auer deference in a manner likely to have the practical effect of eroding the ability of administrative agencies to rely upon the doctrine as a complete defense to legal challenges....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!